A carregar...
TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer
Aberrant activation of beta-catenin/TCF (T-cell factor) signaling is frequently observed in the pancreatic cancer. However, the regulation of nuclear beta-catenin/TCF transcription machinery remains largely unknown. In this study, TFCP2 (transcriptional factor CP2) expression in pancreatic cancer wa...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5642575/ https://ncbi.nlm.nih.gov/pubmed/29050300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19741 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|